免疫原
The antiserum was produced against synthesized peptide derived from human AML1 around the phosphorylation site of Ser303. AA range:269-318
特异性
Phospho-RUNX1 (S276) Polyclonal Antibody detects endogenous levels of RUNX1 protein only when phosphorylated at S276.
组成（Formulation）
Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
稀释比例
WB: 1/500 - 1/2000. IHC: 1/100 - 1/300. ELISA: 1/5000.. IF 1:50-200
纯化工艺（Immunogen）
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
背景（Background）
Core binding factor (CBF) is a heterodimeric transcription factor that binds to the core element of many enhancers and promoters. The protein encoded by this gene represents the alpha subunit of CBF and is thought to be involved in the development of normal hematopoiesis. Chromosomal translocations involving this gene are well-documented and have been associated with several types of leukemia. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008],
功能
alternative products:Additional isoforms seem to exist,caution:The fusion of AML1 with EAP in T-MDS induces a change of reading frame in the latter resulting in 17 AA unrelated to those of EAP.,disease:A chromosomal aberration involving RUNX1/AML1 is a cause of chronic myelogenous leukemia (CML). Translocation t(3;21)(q26;q22) with EAP, MSD1 or EVI1.,disease:A chromosomal aberration involving RUNX1/AML1 is a cause of chronic myelomonocytic leukemia. Inversion inv(21)(q21;q22) with USP16.,disease:A chromosomal aberration involving RUNX1/AML1 is a cause of M2 type acute myeloid leukemia (AML-M2). Translocation t(8;21)(q22;q22) with RUNX1T1/MTG8/ETO.,disease:A chromosomal aberration involving RUNX1/AML1 is a cause of therapy-related myelodysplastic syndrome (T-MDS). Translocation t(3;21)(q26;q22) with EAP, MSD1 or EVI1.,disease:A chromosomal aberration involving RUNX1/AML1 is found in child
蛋白名称
Runt-related transcription factor 1
其他名称
Acute myeloid leukemia 1;Acute myeloid leukemia 1 protein;alpha subunit core binding factor;AML 1;AML1;AML1 EVI 1;AML1 EVI 1 fusion protein;Aml1 oncogene;AMLCR 1;AMLCR1;CBF alpha 2;CBF-alpha-2;CBFA 2;CBFA2;Core binding factor alpha 2 subunit;Core binding factor runt domain alpha subunit 2;Core-binding factor subunit alpha-2;EVI 1;EVI1;HGNC;Oncogene AML 1;Oncogene AML-1;OTTHUMP00000108696;OTTHUMP00000108697;OTTHUMP00000108699;OTTHUMP00000108700;OTTHUMP00000108702;PEA2 alpha B;PEA2-alpha B;PEBP2 alpha B;PEBP2-alpha B;PEBP2A2;PEBP2aB;Polyomavirus enhancer binding protein 2 alpha B subunit;Polyomavirus enhancer-binding protein 2 alpha B subunit;Run1;Runt related transcription factor 1;Runt-related transcription factor 1;RUNX 1;Runx1;RUNX1_HUMAN;SL3 3 enhancer factor 1 alpha B subunit;SL3-3 enhancer factor 1 alpha B subunit;SL3/AKV core binding factor alpha B subunit;SL3/AKV core-binding factor alpha B subunit;PEBP2-alpha
Fields
>>Tight junction;>>Th17 cell differentiation;>>Pathways in cancer;>>Transcriptional misregulation in cancer;>>Chronic myeloid leukemia;>>Acute myeloid leukemia
组织表达
Expressed in all tissues examined except brain and heart. Highest levels in thymus, bone marrow and peripheral blood.
联系我们
关注我们
您当前的位置： 
说明书
成功添加到购物车
